Cover Image

Problems with FDA's regulation of the antiarrhythmic drugs Tambocor and Enkaid : hearing before the Human Resources and Intergovernmental Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, April 10, 1991.

Bibliographic Details
Corporate Authors:	United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1992.
Series:	U.S. Congressional Hearings.
Subjects:	United States. > Food and Drug Administration. Cardiovascular agents > United States. Arrhythmia > Treatment > United States. Drugs > Administration > Government policy > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Antiarrhythmic drugs /
Published: (1989)

Antiarrhythmic drugs : a practical guide /
by: Fogoros, Richard N.
Published: (2007)

Pharmacology of antiarrhythmic agents /
Published: (1981)

Antiarrhythmic drugs : mechanisms of antiarrhythmic and proarrhythmic actions /
Published: (1995)

Antiarrhythmic drugs : a practical guide /
by: Fogoros, Richard N.
Published: (2007)

Novel therapeutic targets for antiarrhythmic drugs /
Published: (2010)

Drugs in cardiology /
by: Donoso, Ephraim
Published: (1975)

Drugs for the heart /
Published: (2009)

Recent developments in cardiovascular drugs /
Published: (1982)

Drugs for the heart /
by: Opie, Lionel H.
Published: (2005)

Sudden cardiac death and congestive heart failure : diagnosis and treatment : proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982 /
Published: (1983)

Drugs for the heart /
Published: (2009)

New cardiovascular drugs.
Published: (1985)

FDA drug bulletin.
Published: (1971)

FDA narcotic treatment programs directory.

FDA fights rare diseases : new help for patients without treatments.
Published: (2002)

FDA's regulation of the drug "Triazure" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session, October 27, 1976.
Published: (1976)

New drugs annual, cardiovascular drugs.
Published: (1983)

Cardiovascular drugs /
Published: (1986)

FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Published: (1995)

FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress /
by: Bodie, Agata
Published: (2021)

Quick reference to cardiovascular pharmacotherapy /
Published: (2003)

Cardiovascular drugs and therapy.

Cardiovascular drugs and therapy /
Published: (1987)

Cardiovascular drugs and the management of heart disease /
Published: (1982)

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987.
Published: (1988)

FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)

La FDA combate las enfermedades raras : nueva ayuda para pacientes sin tratamientos.
Published: (2002)

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
Published: (1988)

Arrhythmia treatment and therapy : evaluation of clinical trial evidence /
Published: (2000)

FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session /
Published: (1972)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

The Food and Drug Administration (FDA) /
Published: (2003)

Early arrhythmias resulting from myocardial ischaemia : mechanisms and prevention by drugs /
Published: (1982)

Cardiovascular pharmacotherapeutics /
by: Frishman, William H., 1946-
Published: (1997)

Journal of cardiovascular pharmacology.
Published: (1979)

Current cardiovascular drugs /
Published: (2000)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978.
Published: (1978)